Delivery Order SPE2DB22D2005-SPE2DB25FJNV3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,437.98 to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 18, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, aligning with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $4,515.92 to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-competitive delivery order represents a firm fixed-price pharmaceutical supply transaction to be performed at the vendor's Conshohocken, Pennsylvania location. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive portfolio of pharmaceutical products...
- The Defense Logistics Agency awarded a $15,269.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to the company's...
- The Defense Logistics Agency awarded a $12,754.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 ml pens on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's established portfolio of pharmaceutical...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on June 17, 2025, with an ultimate completion date of June 18, 2025. This firm fixed price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used for diabetes management, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a delivery order valued at $5,108.64 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pens on August 26, 2025, with an ultimate completion date of August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a prescription medication used in diabetes management, consistent...
- The Defense Logistics Agency awarded a $26,741.23 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pens on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed-price, non-set-aside contract represents a routine pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through...
- The Defense Logistics Agency awarded a $71,465.51 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication, consistent with AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,632.54 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive portfolio of...
- The Defense Logistics Agency awarded a $5,420.32 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens. This firm fixed-price contract, which is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, represents a competitively awarded procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJNV3Delivery Order
The Defense Logistics Agency awarded a $3,381.47 delivery order to AmerisourceBergen Drug Corp for Mounjaro 2.5 mg/0.5 mL pens on June 20, 2025, with completion expected by June 23, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, aligning with AmerisourceBergen's extensive portfolio of pharmaceutical products supplied to federal health systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal health systems worldwide. As a major pharmaceutical distributor, AmerisourceBergen fulfills critical medical supply needs across multiple therapeutic domains through competitively awarded contracts with the Defense Logistics Agency's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/20/25 |